Director of Vaccine Development
Sophie joined EVI in January 2010, and is responsible for overseeing pharmaceutical and subsequent production of vaccine candidates, as well as ad hoc clinical development. In 2014 she was promoted to Vaccine Development Leader.
Until 2001, Sophie worked as a Scientific Researcher in the Molecular Parasitology Laboratory and Applied Genetics Laboratory of l’Université Libre de Bruxelles (ULB), before joining Henogen, Belgium as Chief Scientific Officer and Head of Henogen’s Proprietary Products Platform. During the 2000s, Sophie was in charge of the development of several biotech derived human drugs and vaccines.
Sophie graduated in 1984 with a Master’s degree in Molecular Zoology from ULB, followed by a PhD in Sciences, which she obtained in 2001. She underwent extensive training in the field of Good Manufacturing Practice and Good Clinical Practice. Sophie has submitted several successful patent applications and has authored and co-authored numerous scientific articles in peer reviewed journals.